Centiva Capital’s Cerence CRNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-34,540
Closed -$369K 1750
2025
Q4
$369K Buy
+34,540
New +$379K ﹤0.01% 802
2025
Q1
Sell
-44,570
Closed -$350K 1631
2024
Q4
$350K Buy
+44,570
New +$224K 0.01% 1048
2024
Q3
Sell
-27,799
Closed -$78.7K 2222
2024
Q2
$78.7K Buy
+27,799
New +$198K ﹤0.01% 1882
2023
Q4
Sell
-18,174
Closed -$370K 1870
2023
Q3
$370K Buy
+18,174
New +$457K 0.01% 1086
2021
Q3
Sell
-6,671
Closed -$712K 1333
2021
Q2
$712K Buy
6,671
+4,314
+183% +$425K 0.02% 704
2021
Q1
$211K Buy
+2,357
New +$259K 0.01% 949

Other funds holding CRNC

Centiva Capital's CRNC Position: Q1 2026 in Review

Centiva Capital sold out of Cerence (CRNC) in Q1 2026, closing a stake of 34,540 shares — an estimated $369K sold.

Centiva Capital first reported a position in CRNC in Q1 2021 and held it in 6 quarters. The position peaked at $712K in Q2 2021. 195 funds tracked by Wall St. Rank hold CRNC as of Q1 2026.

  • Centiva Capital reported no remaining Cerence position as of Q1 2026 after selling out during the quarter.
  • Centiva Capital sold 34,540 Cerence shares in Q1 2026, an estimated $369K.
  • Centiva Capital first reported a position in Cerence in Q1 2021 and held it in 6 quarters.
  • Centiva Capital's Cerence position peaked at $712K in Q2 2021.
  • 195 funds tracked by Wall St. Rank held Cerence as of Q1 2026.

Based on Centiva Capital's 13F filing for Q1 2026, filed 14 May 2026.